Research Grants show all

NIH7

Patents show all

Chimerix has 2 licensable patents.
85Applications54Issued

Clinical Trials show all

4Phase 33N/A3Phase 22Phase 11Phase 1/Phase 21Phase 2/Phase 3

SEC Filings show all

8-K6210-Q1410-K4D3S-11

SEC Form D Funding Events

DateOfferedSoldType
2011-02-15$68,749,994$45,000,010Equity, Option to Acquire, Security to be Acquired
2009-08-07$16,145,011$16,130,011Equity
2007-03-12UnknownUnknownOther (Paper Filing)

Key Executives

  • George Painter, Ph.D.
    Executive Officer, Director
  • Graham K. Crooke, M.B.B.S.
    Director
  • Martha J. Demski
    Director
  • Edward E. Penhoet, Ph.D.
    Director
  • Seth A. Rudnick, M.D.
    Director
  • Timothy J. Wollaeger
    Director
  • Kenneth I. Moch
    Executive Officer
  • Merrick Almond, Ph.D.
    Executive Officer
  • Rosemary O'Mahony, Ph.D.
    Executive Officer
  • George Painter, Ph.D
    Executive Officer, Director
  • Gwendolyn P. Painter, M.D., MPH
    Executive Officer
  • Farah Champsi
    Director
  • Arthur M. Pappas
    Director
  • James Niedel
    Director